Once-Weekly Insulin for Type 2 Diabetes: Exploring the Science, Clinical Potential, and Practical Considerations
In this episode of the GSA Momentum Discussions Podcast, Rodolfo Galindo, MD, discusses once-weekly basal insulin therapy for adults with type 2 diabetes. He explores the scientific rationale for reducing basal injection frequency, reviews key clinical findings, examines safety and patient-selection considerations, and discusses how this emerging option may fit into individualized diabetes care. Support provided by Novo Nordisk. Transcript Speaker Rodolfo Galindo, MD Associate Professor, Department of Medicine Emory University School of Medicine Assistant Professor of Medicine, Department of Medicine Division of Endocrinology Emory University School of Medicine Host Jennifer Pettis, MS, RN, CNE Director, Strategic Alliances Gerontological Society of America







